Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Tivic Health Systems, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
TIVC
Nasdaq
3840
tivichealth.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Tivic Health Systems, Inc.
CEO Letter to Shareholders Issued by Tivic Health
- Dec 23rd, 2024 9:54 pm
Tivic Health Systems Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$1.48 loss in 3Q 2023)
- Nov 17th, 2024 2:22 pm
Tivic hits enrolment target for vagus nerve stimulation trial
- Nov 15th, 2024 4:46 pm
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update
- Nov 15th, 2024 4:36 am
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
- Nov 14th, 2024 1:45 pm
Tivic Health Validates European Patents in Great Britain, Germany, and France
- Nov 12th, 2024 1:30 pm
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14
- Nov 7th, 2024 1:30 pm
First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device
- Oct 29th, 2024 12:00 pm
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024
- Oct 24th, 2024 12:30 pm
Tivic Health Gets Institutional Review Board's Approval for ncVNS Optimization Study
- Sep 18th, 2024 2:33 pm
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment
- Sep 18th, 2024 1:00 pm
Tivic Health Accelerates VNS Commercial Strategy Development
- Sep 17th, 2024 1:00 pm
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer
- Sep 13th, 2024 9:29 pm
Tivic Reports Second Quarter 2024 Financial Results
- Aug 14th, 2024 8:15 pm
Tivic Health to Report Q2 2024 Financial Results and Corporate Update on August 14th Via Conference Call and Webcast
- Aug 6th, 2024 1:15 pm
Tivic Announces 2024 Annual Meeting of Stockholders
- Aug 2nd, 2024 1:15 pm
Tivic Health Expands Intellectual Property Portfolio
- Jul 23rd, 2024 2:00 pm
Tivic Health: Christina Valauri Appointed to Board of Directors
- Jun 18th, 2024 1:15 pm
Tivic Health Partners with the Feinstein Institutes to Advance its Patent-pending, Non-Invasive Cervical Vagus Nerve Stimulation; Begins Optimization of ncVNS for use in Clinical Indications
- May 22nd, 2024 1:00 pm
Tivic Reports First Quarter 2024 Financial Results and Subsequent Events
- May 15th, 2024 8:26 pm
Scroll